Women of Teal is a play on the words "Man of Steel" used to describe Superman. I have found my fellow ovarian cancer survivors to be the strongest, most helpful women in the world. They are truly Women of Teal!
I hope women diagnosed with ovarian cancer who live in New Jersey and around the country will find this site useful.

Oral Abstract Frenel Discussed the use of pembrolizumab ( anti-PD1) in 24 women with advanced cervical cancer in a phase 1 trial - KEYNOTE trial (5515) . Pembrolizumab was well tolerated and had promising anti-tumor activity.

Soliman Discussed everolumis, letrozole, and metformin in recurrent/advanced endometrial cancer. (5506) the study showed that 67% of the women treated with the combined therapy showed a clinical benefit. There was no difference in clinical benefit for those with the KRAS mutation. Side effects included anemia , diarrhea and fatigue.

Poster Session5518 Clinically applicable molecular-based classification for endometrial cancers.
MMR, immunohistochemistry (IHC), mutation status of the POLE exonuclease domain, and p53 IHC were evaluated on a cohort of 456 endometrial hysterectomy specimens. POLE had the best prognosis while the P53 had the worst prognosis. The "molecular classification tool can be used from time of first diagnosis
and will: provide consistent categorization of tumors, improve risk
stratification, identify women who may have Lynch syndrome, stratify
clinical trials, and we believe ultimately improve outcomes for women
with EC."

Gyn Cancer Blogs

Other Helpful Blogs

Disclaimer:

Certain entries in this blog deal with health and medical related issues. Always seek the advice of a trained health professional with any questions you may have regarding ovarian cancer. The information on this blog is not intended to replace proper medical care.